Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.

about

Technological Microbiology: Development and Applications Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines.

P2860

Q30250972-7485260E-2398-4793-9ECA-9B15D2DF0FAB Q48169265-4C784E61-676B-40F7-A0FB-565925B6F175

P2860

Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.

Item

http://www.wikidata.org/entity/Q39169715

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.

@en

Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.

@nl

type

Item

label

Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.

@en

Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.

@nl

prefLabel

Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.

@en

Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.

@nl

P1476

Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.

@en

P2093

Carlo Pifferi

http://www.w3.org/2001/XMLSchema#string

Nathalie Berthet

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

The development of synthetic antitumour vaccines from mucin glycopeptide antigens

Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses

Immunogenicity and protective efficacy of Bacillus anthracis poly-gamma-D-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy.

Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.

On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.

Toward automated synthesis of oligosaccharides and glycoproteins.

The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice

P304

953-965

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C7BM00072C

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Renaudet

Carlo Pifferi

Nathalie Berthet

P577

2017-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28275765

http://www.w3.org/2001/XMLSchema#string

Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.

about

P2860

P2860

Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698